{
    "code": "51058094",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51058094",
    "time": "2018-08-31 04:28:13",
    "許可證字號": "衛部藥製字第058094號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/10\/09",
    "發證日期": "102\/10\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY05105809409",
    "中文品名": "&quot;永信&quot;鉑瑞停注射液5毫克\/毫升",
    "英文品名": "Folep Injection 5mg\/ml &quot;Yung Shin&quot;",
    "適應症": "和5-fluorouracil(5-FU)及folinic acid(FA)併用，作為-第三期結腸癌(Duke's C)原發腫瘤完全切除手術後的輔助療法。-治療轉移性結腸直腸癌。Oxaliplatin和Capecitabine併用可用於局部晚期及復發\/轉移性胃癌之治療。",
    "劑型": "270注射劑",
    "包裝": "10毫升、20毫升、40毫升玻璃小瓶裝 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "OXALIPLATIN"
    ],
    "限制項目": "01國　產 24監視期滿學名藥",
    "申請商名稱": "0502110200  永信藥品工業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0502110300  永信藥品工業股份有限公司台中幼獅廠",
        "製造廠廠址": "台中市大甲區工七路9號、工九路27號",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012001600",
            "成分名稱": "OXALIPLATIN",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "510580940001-107-05-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058094&Seq=005&Type=9"
        },
        {
            "title": "510580940002-105-08-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058094&Seq=004&Type=9"
        },
        {
            "title": "510580940010-102-11-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058094&Seq=008&Type=8"
        }
    ]
}